Figure 4.
TGF-β receptor activity. (A) Estimation of TGFβR1/2 activity by measurement of TGFβR1 phosphorylation. Results are expressed as the ratio of pTGFβR1/TGFβR1. *Significant decrease in TGFβR1 phosphorylation in aneurysmal media from patients with TGFBR2 mutations (Q508Q and R357C) compared with controls and other types of TAA (P < 0.05). (B) Dissociation between Smad2 activation and TGF-β receptor activity in aneurysmal SMCs. *P < 0.01, treated vs. non-treated conditions. #P < 0.05 vs. control.